| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
20,593 |
16,952 |
$2.11M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,572 |
9,258 |
$108K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,519 |
1,415 |
$22K |
| 36415 |
Collection of venous blood by venipuncture |
1,344 |
1,254 |
$21K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
577 |
518 |
$9K |
| 90686 |
|
441 |
395 |
$8K |
| 90837 |
Psychotherapy, 53 minutes with patient |
271 |
155 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
406 |
378 |
$3K |
| 81002 |
|
85 |
74 |
$3K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
53 |
45 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,694 |
2,342 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
99 |
85 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
34 |
28 |
$959.61 |
| 87631 |
|
125 |
117 |
$706.74 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
243 |
231 |
$94.67 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
2,996 |
2,612 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
15 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
97 |
86 |
$0.00 |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
101 |
74 |
$0.00 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
13 |
13 |
$0.00 |
| 90694 |
|
17 |
12 |
$0.00 |
| 90651 |
|
14 |
13 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
17 |
14 |
$0.00 |
| 90656 |
|
13 |
13 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
102 |
47 |
$0.00 |
| 90734 |
|
21 |
19 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
175 |
165 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
43 |
34 |
$0.00 |
| 90715 |
|
15 |
13 |
$0.00 |